Kuros Biosciences announces changes in the Board of Directors

Ad-hoc announcement pursuant to Article 53 of the SIX listing rules

Kuros Biosciences announces changes in the Board of Directors

Schlieren (Zurich), Switzerland, September 4, 2025 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, announces that Albert Arp has decided to resign from the Board of Directors with immediate effect for personal and professional reasons.

Oliver Walker was appointed as Chair of the Audit and Risk Committee. Kimberley Elting was appointed as member of the Audit and Risk Committee and as member and Chair of the Compensation and Nomination Committee.

The Board of Directors respects Albert Arp’s decision and would like to thank him for his services and wishes him all the best for the future.